Ashwani Kumar is an Indian microbiologist and the senior principal scientist at the Institute of Microbial Technology (ImTech).
His laboratory hypothesizes that tuberculosis is a biofilm infection, so its treatment needs the administration of multiple drugs for at least six months.
For his contributions in tuberculosis pathogenesis, he was awarded with Shanti Swarup Bhatnagar Prize for Science and Technology 2022.
[3] He is known to have done extensive research on Mycobacterium tuberculosis and has served as a member of MDRIpred project,[4] an open source server for predicting inhibitors against drug-tolerant M.tb H37Rv.
[7] His laboratory has demonstrated the presence of cellulose encased biofilms[8] inside the hosts including human.